Capacitive sensing for drug delivery

US2023398290A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2023398290-A1
Application numberUS-202118034623-A
CountryUS
Kind codeA1
Filing dateMar 11, 2021
Priority dateOct 30, 2020
Publication dateDec 14, 2023
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Processes for using a capacitive sensor to control drug delivery are described. The capacitive sensor measures a capacitance across a pair of electrodes arranged along either side of a container. The container includes an air chamber, a fluid chamber, and a stopper separating the air chamber from the fluid chamber. A volume of drug in the fluid chamber may be determined based on the measured capacitance. The volume is compared to a target volume, and if the volume in the fluid chamber is greater than the target volume, a stopper actuator expels a portion of the drug from the fluid chamber.

First claim

Opening claim text (preview).

What is claimed is: 1 . A method for monitoring delivery of a drug, the method comprising: measuring a capacitance across a pair of electrodes, the pair of electrodes arranged along either side of a container, the container comprising an air chamber, a fluid chamber, and a stopper separating the air chamber from the fluid chamber; determining, based on the measured capacitance, a volume of a drug in the fluid chamber; comparing the volume of the drug in the fluid chamber to a target volume; and in response to the volume of the drug in the fluid chamber being greater than the target volume, instructing a stopper actuator to expel at least a portion of the drug from the fluid chamber. 2 . The method of claim 1 , further comprising: receiving a temperature measurement from a temperature sensor; and determining the volume of the drug in the fluid chamber based on the temperature measurement, wherein a relative permittivity of sensor dielectric depends on temperature. 3 . The method of claim 1 , further comprising: receiving a humidity measurement from a humidity sensor; and determining the volume of the drug in the fluid chamber based on the humidity measurement, wherein a relative permittivity of sensor dielectric depends on humidity. 4 . The method of claim 1 , further comprising: measuring a baseline volume of the drug in the fluid chamber prior to expelling the drug from the fluid chamber; and calculating the target volume based on the baseline volume. 5 . The method of claim 1 , wherein the measured capacitance is a first capacitance, the method further comprising: after instructing the stopper actuator to expel the drug from the fluid chamber, measuring a second capacitance across the pair of electrodes; and in response to a difference between the first capacitance and the second capacitance being less than an error threshold, determining that a failure has occurred. 6 . The method of claim 5 , further comprising: receiving at least one of a fluid chamber pressure from a pressure sensor and a stopper actuator power from a power sensor; and in response to at least one of the fluid chamber pressure exceeding a threshold pressure and the stopper actuator power exceeding a threshold power, determining that the failure is an occlusion. 7 . The method of claim 5 , further comprising: receiving at least one of a fluid chamber pressure from a pressure sensor and a stopper actuator power from a power sensor; and in response to at least one of the fluid chamber pressure being lower than a threshold pressure and the stopper actuator power being lower than a threshold power, determining that the failure is a leakage. 8 . The method of claim 1 , further comprising: prior to instructing the stopper actuator to expel the drug from the fluid chamber, performing a leakage detection procedure comprising: obtaining a first capacitance measurement; obtaining a second capacitance measurement a period of time after the first capacitance measurement; and comparing the first capacitance measurement to the second capacitance measurement to determine whether the second capacitance measurement is within a threshold tolerance of the first capacitance measurement. 9 . A method for delivering a drug comprising: determining a target capacitance for a drug dose; measuring a capacitance across a pair of electrodes, the pair of electrodes arranged along either side of a container, the container comprising an air chamber, a fluid chamber, and a stopper separating the air chamber from the fluid chamber; comparing the measured capacitance to the target capacitance; and in response to the measured capacitance being greater than the target capacitance, instructing a stopper actuator to expel at least a portion of the drug from the fluid chamber. 10 . The method of claim 9 , further comprising: receiving a temperature measurement from a temperature sensor; and determining the target capacitance for the drug dose based on the temperature measurement, wherein a relative permittivity of sensor dielectric depends on temperature. 11 . The method of claim 9 , further comprising: receiving a humidity measurement from a humidity sensor; and determining the target capacitance for the drug dose based on the humidity measurement, wherein a relative permittivity sensor dielectric depends on humidity. 12 . The method of claim 9 , further comprising: measuring a baseline capacitance prior to expelling the drug from the fluid chamber; and calculating the target capacitance based on the baseline capacitance. 13 . The method of claim 9 , wherein the measured capacitance is a first capacitance, the method further comprising: after instructing the stopper actuator to expel the drug from the fluid chamber, measuring a second capacitance across the pair of electrodes; and in response to a difference between the first capacitance and the second capacitance being less than an error threshold, determining that a failure has occurred. 14 . The method of claim 13 , further comprising: receiving at least one of a fluid chamber pressure from a pressure sensor and a stopper actuator power from a power sensor; and in response to at least one of the fluid chamber pressure exceeding a threshold pressure and the stopper actuator power exceeding a threshold power, determining that the failure is an occlusion. 15 . The method of claim 13 , further comprising: receiving at least one of a fluid chamber pressure from a pressure sensor and a stopper actuator power from a power sensor; and in response to at least one of the fluid chamber pressure being lower than a threshold pressure and the stopper actuator power being lower than a threshold power, determining that the failure is a leakage. 16 . The method of claim 9 , further comprising: prior to instructing the stopper actuator to expel the drug from the fluid chamber, performing a leakage detection procedure comprising: obtaining a first capacitance measurement; obtaining a second capacitance measurement a period of time after the first capacitance measurement; and comparing the first capacitance measurement to the second capacitance measurement to determine whether the second capacitance measurement is within a threshold tolerance of the first capacitance measurement. 17 . A method for characterizing a drug comprising: measuring a capacitance across a pair of electrodes, the pair of electrodes arranged along either side of a container, the container containing a drug; determining an expected capacitance across the pair of electrodes, the expected capacitance based on an expected volume of the drug in the container and an expected relative permittivity of the drug; comparing the measured capacitance to the expected capacitance; and in response to the measured capacitance being outside a tolerance threshold of the expected capacitance, outputting an alert. 18 . The method of claim 17 , further comprising: receiving a temperature measurement from a temperature sensor; and determining the expected capacitance based on the temperature measurement, wherein a relative permittivity of sensor dielectric depends on temperature. 19 . The method of claim 17 , the container further comprising an air chamber between the electrodes, the method further comprising: receiving a humidity measurement from a humidity sensor; and determining the expected capacitance based on the humidity measurement, wherein a relative permittivity of sensor dielectric depends

Assignees

Inventors

Classifications

  • by controlling the degree of opening of the flow line · CPC title

  • pressurised by means of pistons · CPC title

  • by monitoring line pressure · CPC title

  • Measuring · CPC title

  • Masses, volumes, levels of fluids in reservoirs, flow rates · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2023398290A1 cover?
Processes for using a capacitive sensor to control drug delivery are described. The capacitive sensor measures a capacitance across a pair of electrodes arranged along either side of a container. The container includes an air chamber, a fluid chamber, and a stopper separating the air chamber from the fluid chamber. A volume of drug in the fluid chamber may be determined based on the measured ca…
Who is the assignee on this patent?
Analog Devices Inc
What technology area does this patent fall under?
Primary CPC classification A61M5/16813. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Dec 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).